TL;DR
This study investigates hypervirulent Klebsiella pneumoniae (HvKp) in swine, revealing that a swine-derived strain (ST25 lineage) is closely related to human clinical isolates, suggesting zoonotic transmission. The research identifies capsule synthesis as a key virulence factor and demonstrates the efficacy of phage therapy as a promising treatment against these dangerous pathogens.
What Problem Does This Paper Address?
The emergence of multidrug-resistant hypervirulent Klebsiella pneumoniae (MDR-HvKp) is a significant global health threat due to its high mortality, rapid spread, and limited treatment options. While human strains of HvKp have been extensively studied, those originating from animals, particularly food animals, are poorly understood. This lack of knowledge hinders our ability to implement effective surveillance and control strategies, especially given the potential for zoonotic transmission. This paper aims to bridge this gap by characterizing a hypervirulent K. pneumoniae strain isolated from swine, investigating its evolutionary origins, identifying its virulence determinants, and exploring potential therapeutic interventions.
Methods
The researchers employed a multi-pronged approach:
- Bacterial Isolation and Identification: A hypervirulent K. pneumoniae strain (KPB) was isolated from a diseased pig on a Chinese swine farm exhibiting high mortality.
- Whole Genome Sequencing and Analysis: The KPB strain's genome was sequenced using PacBio and Illumina platforms. This allowed for de novo assembly, functional annotation of genes, and identification of virulence and antimicrobial resistance genes.
- Phylogenomic Analysis: A large dataset of 342 K. pneumoniae genomes, including the KPB strain, was analyzed using core-genome SNP (cgSNP) phylogenetic analysis to understand the evolutionary relationships and global distribution of the ST25 lineage.
- In Vivo Virulence Assays: Mouse models were used to determine the median lethal dose (LD50) of the KPB strain and its isogenic mutants. Swine were also used to assess the pathological consequences of infection.
- Functional Assays: Isogenic mutants were created by knocking out specific virulence genes (e.g., rmpA, iroB, wcaJ, wzc, peg-344). These mutants were then used to assess their roles in mucoviscosity, uronic acid production (indicators of capsule synthesis), bacterial adhesion to epithelial cells, and phagocytosis by macrophages.
- Plasmid Stability and Transfer Assays: The ability of the virulence plasmid to be transferred to other bacterial species (E. coli) and its stability over time were investigated.
- Phage Therapy: A lytic bacteriophage (vB_KpnP_B1) was isolated and characterized. Its therapeutic efficacy was evaluated in a mouse model of KPB infection.
Datasets
- Genomic Data: 22,509 publicly available K. pneumoniae genomes from the NCBI database were screened. A subset of 342 ST25 isolates were selected for detailed phylogenetic analysis. Additional genomes from ST11, ST23, and other high-risk lineages were included for comparative analysis.
- No new benchmarks were introduced.
Key Insights and Ideas
- Swine as a Reservoir for Zoonotic HvKp: The study strongly suggests that swine can act as a reservoir for hypervirulent K. pneumoniae, specifically the ST25 lineage, which is closely related to human clinical isolates. This highlights the potential for zoonotic transmission and the need for integrated "One Health" surveillance.
- Capsule Synthesis is Paramount for Virulence: The research definitively shows that the wcaJ/wzc-mediated capsule synthesis is a critical determinant of KPB's hypervirulence. Mutants lacking these genes were completely avirulent in mouse models, underscoring the importance of the capsule in evading host defenses and establishing infection.
- Phage Therapy as a Potent Weapon: The development and successful application of a specific bacteriophage (vB_KpnP_B1) demonstrated 100% survival in a lethal mouse infection model, even with delayed administration. This offers a promising alternative to antibiotics, especially against drug-resistant strains.
- Evolutionary Convergence: The findings suggest an evolutionary convergence between animal and human HvKp strains, indicating that similar virulence mechanisms are selected for in different host environments.
Key Results
- The isolated swine HvKp strain KPB exhibited extreme virulence with an LD50 of 20 CFU in mice.
- Phylogenomic analysis revealed that the swine-derived KPB (ST25) clusters closely with human clinical isolates.
- Capsule-deficient mutants (wcaJ/wzc deletion) showed a 100% reduction in lethality in mouse infection models.
- Phage therapy with vB_KpnP_B1 achieved 100% survival in infected mice at a dose of 2.0×10¹ PFU.
- Deletion of rmpA and siderophore-related genes (iucABCD-iutA, iroB) also attenuated virulence, but to a lesser extent than capsule-deficient mutants.
- The virulence plasmid pKPB_Vir demonstrated efficient horizontal transfer to E. coli and was stable over 30 days in transconjugants.
- Swine infected with KPB showed severe systemic pathology, including hemorrhagic consolidation and inflammatory infiltrates, validating the swine model for studying HvKp pathogenesis.
Limitations and Future Work
- Limited Scope of Phage Therapy: While promising, the phage therapy was only tested in a mouse model. Further studies are needed to evaluate its efficacy in larger animal models and in clinical settings.
- Mechanisms of Iron Acquisition: While siderophore mutants showed reduced virulence, partial lethality remained, suggesting compensatory iron uptake mechanisms that warrant further investigation.
- Host-Specific Adaptations: Although evolutionary convergence is suggested, further research could explore subtle host-specific adaptations in virulence factor expression or regulation.
- Broader Surveillance: The study emphasizes the need for expanded "One Health" surveillance to monitor the circulation of ST25 and other HvKp lineages across different host species and environments.
- Phage Resistance: While the study found no evidence of phage resistance in surviving mice, long-term and widespread phage use could potentially select for resistant strains, which needs to be monitored.
Summary updated